Hip surgery pain relief: new nerve block shows promise
NCT ID NCT07023107
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a specific nerve block called PENG, using the numbing drug ropivacaine, could reduce surgical stress and pain after total hip replacement. Sixty older adults (ages 60-100) scheduled for hip surgery under spinal anesthesia received either the nerve block or a placebo (salt water). The main goal was to see if the block lowered inflammation markers in the blood and delayed the need for painkillers.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ropivacaine
What this could lead to
If it works, this could offer a better way to manage pain after hip replacement, reducing the need for strong opioids.
What could go wrong
This is a small, completed Phase 4 trial with only 60 participants, so results may not apply to everyone. The nerve block is a temporary procedure and does not change the underlying condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIP PAIN CHRONIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Poznan University of Medical Sciences
Poznan, Poland